Churchill Downs Incorporated
CHDN
$81.91
-0.38%
Churchill Downs Incorporated is a gaming entertainment, online wagering, and horse racing company operating through three segments: Live and Historical Racing (pari-mutuel racing at flagship properties including Churchill Downs Racetrack), Wagering Services (TwinSpires online advance-deposit wagering and retail/online sports betting), and Gaming (slot machines, video lottery terminals, video poker, and historical horse racing machines across casino properties). The company occupies a uniquely hybrid position in the Consumer Cyclical / Gambling, Resorts & Casinos industry — it is simultaneously the steward of America's most iconic racing asset (the Kentucky Derby) and a regional casino operator competing with pure-play gaming peers, giving it a brand moat that few regional operators can replicate. The current investor narrative centers on the April 2026 definitive agreement to acquire the Preakness Stakes intellectual property rights, which management frames as a new, stable revenue stream that deepens the company's portfolio of premier racing assets and cements a Triple Crown trifecta of owned events. Against that strategic ambition, the stock has been a notable laggard — down double digits over the past year and sharply underperforming the S&P 500 — as investors weigh heavy leverage, a soft gaming demand backdrop, and the capital intensity of the historical racing machine (HRM) expansion against the long-term cash-flow potential of these marquee asset acquisitions.…
CHDN
Churchill Downs Incorporated
$81.91
Related headlines
Investment Opinion: Should I buy CHDN Today?
The synthesized recommendation is Hold with a contrarian tilt, reflecting the tension between deeply discounted valuation and deteriorating fundamentals. The analyst consensus is unanimously bullish with an average target of $130.58 (59.4% upside) and a low target of $100.00 (22.1% upside), but the stock's 38.53 percentage point year-to-date underperformance versus SPY and its position just 2.1% above the 52-week low suggest the market is pricing in risks that analysts may be underestimating. The core thesis is that the forward PE of 11.06x versus the trailing PE of 21.23x creates an asymmetric risk/reward if the $8.29 EPS estimate is achieved, but the 1.66x interest coverage and 0.604 current ratio mean there is limited margin for error.
Supporting evidence for a constructive view includes the $605 million TTM free cash flow, which provides substantial capacity to service $75.6 million in quarterly interest expense and fund growth initiatives. Revenue grew 6.68% year-over-year in Q4 2025, and the Preakness IP acquisition adds a new stable revenue stream that could accelerate growth in 2027. The trailing PE of 21.23x represents a dramatic compression from historical levels of 34-45x, and the PS ratio of 2.76x is down from 12.20x at Q4 2025, placing the stock near the bottom of its multi-year valuation range. However, the EV/EBITDA of 12.13x remains at the upper end of the 8-12x regional casino range, suggesting the market still ascribes a premium for the Derby brand.
The biggest risks that could invalidate the thesis are: (1) failure to achieve the $8.29 forward EPS estimate, which would make the current price expensive on a forward basis; (2) a breach of the $79.40 52-week low triggering further momentum selling; and (3) continued revenue deceleration below 5% that would make deleveraging impossible without equity dilution. The rating would upgrade to Buy if the stock holds the $79.40 support level and Q1 2026 earnings show progress toward the $8.29 EPS target, or downgrade to Sell if revenue growth falls below 4% or interest coverage deteriorates further. On balance, the stock appears undervalued relative to its own history but fairly valued relative to peers, warranting a Hold rating with a bias toward accumulation on weakness.
Sign up to view all
CHDN 12-Month Price Forecast
The risk/reward is balanced but with a positive skew if the earnings recovery materializes, as the forward PE of 11.06x prices in significant pessimism relative to the $8.29 consensus EPS estimate. The primary concern is the 1.66x interest coverage and 0.604 current ratio, which leave minimal margin for error if revenue growth decelerates below 5%. The Preakness IP acquisition provides a credible catalyst for revenue diversification, but its contribution will not be material until 2027, leaving the near-term outlook dependent on HRM expansion and gaming demand stabilization. I would upgrade to bullish if the stock holds $79.40 support and Q1 2026 EPS tracks above $1.50, or downgrade to bearish if revenue growth falls below 4% or the forward EPS estimate is cut below $7.00. The 25% bull, 50% base, and 25% bear probability distribution reflects the high uncertainty around the earnings recovery trajectory.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Churchill Downs Incorporated's 12-month outlook, with a consensus price target around $130.58 and implied upside of +59.4% versus the current price.
Average Target
$130.58
0 analysts
Implied Upside
+59.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$100 - $157
Analyst target range
Twelve analysts cover CHDN, and the consensus is overwhelmingly bullish despite the stock's poor price performance: the average target price is $130.58, which implies approximately 59.4% upside from the current price of $81.91. The target range is wide, spanning from a low of $100.00 (still 22.1% above the current price) to a high of $157.00 (91.7% above current), and notably, even the most conservative analyst target sits well above where the stock trades today. The recommendation field is listed as 'none' in the data, but the institutional ratings history tells a clear story: every single rating in the provided list is a buy-equivalent action — Wells Fargo at Overweight (February 2026 and January 2026), Citizens at Market Outperform (January 2026), Macquarie at Outperform (October 2025 and July 2025), Barclays at Overweight (October 2025 and July 2025), Susquehanna at Positive (October 2025), JP Morgan at Overweight (October 2025), and Mizuho at Outperform (July 2025). There are zero downgrades, holds, or sells in the visible ratings history, indicating that the analyst community remains firmly constructive even as the stock has fallen sharply. The wide target spread — a $57 gap between the $100 low and $157 high — signals meaningful uncertainty about the company's earnings trajectory, which is consistent with the volatile quarterly results and the transformative Preakness acquisition. The high target of $157 likely assumes successful integration of the Preakness IP, accelerating HRM revenue, multiple expansion back toward historical levels, and meaningful deleveraging; the low target of $100 likely assumes slower growth, continued margin pressure from interest expense, and a more conservative re-rating. The consensus estimated EPS of $8.29 (range $7.94 to $8.56) and estimated revenue of $3.21 billion (range $3.16 billion to $3.26 billion) provide the fundamental anchors for these targets, and the tight revenue estimate range suggests analysts have high confidence in the top-line trajectory even if they disagree on profitability and valuation. The persistent gap between the bullish analyst consensus and the bearish price action creates a classic contrarian setup: either the market is wrong and analysts are right, or analysts are lagging a fundamental deterioration that the market has already priced in — and the resolution of that tension will define CHDN's performance over the next several quarters.
Bulls vs Bears: CHDN Investment Factors
The bear case currently holds stronger near-term evidence, with the stock in a sustained downtrend, accelerating negative momentum, and a leveraged balance sheet that is pressuring earnings despite revenue growth. However, the bull case rests on a compelling valuation disconnect: the forward PE of 11.06x versus a trailing PE of 21.23x implies the market expects earnings to double, and analyst targets averaging $130.58 suggest 59.4% upside. The single most important tension is whether the forward EPS estimate of $8.29 is achievable — if it is, the stock is deeply undervalued; if it is not, the current price may still be too high given the 1.66x interest coverage and 0.604 current ratio. The resolution of this earnings recovery question, likely tied to Preakness IP integration and HRM expansion, will define the investment outcome over the next 12 months.
Bullish
- Deep Discount to Analyst Targets: The average analyst target price of $130.58 implies 59.4% upside from the current $81.91, and even the lowest target of $100.00 sits 22.1% above the current price. All 12 covering analysts maintain buy-equivalent ratings with zero downgrades in the visible history, suggesting the sell-off is disconnected from fundamental expectations.
- Forward PE Signals Earnings Recovery: The forward PE of 11.06x is roughly half the trailing PE of 21.23x, implying the market expects EPS to roughly double to the consensus estimate of $8.29. If achieved, the stock trades at a significant discount to its historical PE band of 34-45x, offering substantial multiple expansion potential.
- Preakness IP Adds Stable Revenue: The April 2026 definitive agreement to acquire Preakness Stakes intellectual property rights adds a second marquee Triple Crown asset to the portfolio, creating new licensing and sponsorship revenue streams. This deepens the company's brand moat and diversifies away from the seasonal Kentucky Derby concentration.
- Strong Free Cash Flow Generation: Trailing twelve-month free cash flow is $605 million, which covers the $75.6 million quarterly interest expense more than twice over on an annualized basis. This cash generation provides capacity for deleveraging and continued HRM expansion without requiring additional equity issuance.
Bearish
- Extreme Leverage and Thin Coverage: Debt-to-equity stands at 5.15 and total debt-to-capitalization at 83.73%, with interest expense of $75.6 million consuming most of Q4 2025 operating income of $125.2 million. Interest coverage of just 1.66x leaves minimal cushion for any earnings decline, and the current ratio of 0.604 signals limited liquidity.
- Accelerating Negative Price Momentum: The stock is down 10.72% over the past month, worse than the 7.21% three-month decline and 2.17% six-month decline, indicating the downtrend is accelerating. It trades just 2.1% above its 52-week low of $79.40 and has underperformed SPY by 38.53 percentage points year-to-date.
- Earnings Decline Despite Revenue Growth: Q4 2025 net income fell to $49.8 million from $71.7 million in Q4 2024 despite 6.68% revenue growth, as interest expense consumed a disproportionate share of operating income. This divergence between top-line growth and bottom-line contraction highlights the earnings drag from the leveraged capital structure.
- Decelerating Revenue Growth Trajectory: Revenue growth decelerated from 8.7% year-over-year in Q3 2025 to 6.68% in Q4 2025, and Q2 2025 growth of 4.9% was even slower. Mid-single-digit top-line expansion is insufficient to rapidly deleverage a balance sheet with 83.73% debt-to-capitalization.
CHDN Technical Analysis
CHDN is in a sustained downtrend, with the current price of $81.91 sitting just 2.1% above its 52-week low of $79.40 and a staggering 30.8% below its 52-week high of $118.35 — meaning the stock is trading at only about 21% of its 52-week range. The 1-year price change of -15.02% and year-to-date decline of -26.83% confirm persistent selling pressure, and the -31.46% max drawdown underscores that this is a broken chart rather than a garden-variety pullback. Positioning this close to the 52-week low signals a classic 'falling knife' setup: value-oriented buyers may see opportunity, but momentum traders should recognize there is no evidence yet of a durable base. Momentum is deteriorating across every timeframe: the 1-month change of -10.72% is worse than the 3-month change of -7.21%, which is worse than the 6-month change of -2.17%, indicating the decline is accelerating rather than decelerating. This short-term weakness is a stark divergence from the already-negative 1-year trend, and the relative strength figures paint an even grimmer picture — CHDN has underperformed SPY by 9.76 percentage points over the past month and a remarkable 38.53 percentage points year-to-date, while SPY itself gained 11.70% YTD. The most recent price action (from $93.71 on August 21 to $81.91 on September 18) shows a nearly uninterrupted slide, with the stock closing below $83 in seven of the last nine sessions, suggesting sellers remain in control and no capitulation-style volume spike has yet marked a bottom. Key technical levels are well defined: the 52-week low at $79.40 is the critical support zone, and a decisive breakdown below that level would likely trigger further momentum-driven selling and open the door to new lows; the 52-week high at $118.35 represents distant resistance, with intermediate resistance likely forming around the $90-$94 area where the stock repeatedly failed in August and early September. The beta of 0.667 is a meaningful offset — CHDN is roughly one-third less volatile than the broader market, which means position sizing can be larger for the same dollar risk, but it also means the stock will not snap back as violently as high-beta names when sentiment turns. With a short ratio of 4.31 days-to-cover, short interest is moderate rather than extreme, so a violent short squeeze is not the base case, though any positive catalyst could force some covering.
Beta
0.67
0.67x market volatility
Max Drawdown
-31.5%
Largest decline past year
52-Week Range
$79-$118
Price range past year
Annual Return
-15.0%
Cumulative gain past year
| Period | CHDN Return | S&P 500 |
|---|---|---|
| 1m | -10.7% | -0.5% |
| 3m | -7.2% | +2.3% |
| 6m | -2.2% | +16.6% |
| 1y | -15.0% | +14.8% |
| ytd | -26.8% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CHDN Fundamental Analysis
Revenue is growing but at a decelerating pace: the most recent quarter (Q4 2025, ended December 31, 2025) generated $665.9 million in revenue, up 6.68% year-over-year from $624.2 million in Q4 2024. However, the sequential trend is uninspiring — Q3 2025 revenue of $683.0 million was actually higher than Q4, and the Q2 2025 quarter at $934.4 million reflects the seasonal Kentucky Derby bump that dominates the annual revenue pattern. Comparing year-over-year quarters, Q3 2025 revenue of $683.0 million grew 8.7% over Q3 2024's $628.5 million, while Q2 2025's $934.4 million grew 4.9% over Q2 2024's $890.7 million — so growth is positive but in the mid-single-digit range and decelerating from the Q3 pace. Segment data shows the Gaming segment at $248.7 million and Pari-Mutuel/Historical Racing at $261.9 million as the two largest contributors, with Live and Simulcast Racing at $98.2 million and Other products/services at $74.0 million; the growth story is increasingly dependent on the Gaming and HRM businesses rather than the legacy racing operations. The investment case hinges on whether the Preakness IP acquisition and continued HRM buildout can reaccelerate growth, because mid-single-digit top-line expansion is not sufficient to justify the current leverage profile. Profitability is solid but lumpy: the company reported net income of $49.8 million in Q4 2025 on a 7.48% net margin, with a gross margin of 29.54% and an operating margin of 18.80% for that quarter. The trailing twelve-month picture is far stronger — net margin of 12.98%, operating margin of 25.17%, and gross margin of 33.58% — but the quarterly volatility is extreme, with Q2 2025 net income of $216.9 million (23.21% net margin) versus Q4 2025's $49.8 million, driven by the seasonal Derby windfall. Gross margin has been relatively stable in the 29-30% range for Q1, Q3, and Q4 2025, but Q2 2025 spiked to 41.96% due to the Derby, and the Q4 2025 gross margin of 29.54% was actually an improvement over Q4 2024's 28.79%. The key concern is that net income declined year-over-year in Q4 2025 ($49.8 million vs. $71.7 million in Q4 2024) despite revenue growth, as interest expense of $75.6 million consumed a large share of operating income of $125.2 million — interest coverage of just 1.66x is thin. The balance sheet is the company's most significant fundamental risk: debt-to-equity stands at a very elevated 5.15, total debt-to-capitalization is 83.73%, and the current ratio of 0.604 indicates current liabilities substantially exceed current assets, leaving limited liquidity cushion. Free cash flow on a trailing twelve-month basis is $605 million, which is healthy, but the quarterly pattern is erratic — Q4 2025 free cash flow was just $15.9 million after $80.1 million of capital expenditure, while Q3 2025 generated $267.8 million. ROE of 37.61% looks impressive but is heavily inflated by the leveraged capital structure (a company equity multiplier of 7.41x), while ROA of just 6.48% reveals the underlying asset base is not generating particularly high returns. The company is funding growth through a combination of operating cash flow and debt, with Q3 2025 showing $185.3 million of acquisitions and $102.3 million of debt repayment, and the cash position of $288.5 million at year-end 2025 provides some buffer but is modest relative to the debt load. The dividend yield of just 0.38% with a payout ratio of 8.11% signals that capital return is a low priority relative to deleveraging and reinvestment.
Quarterly Revenue
$665900000.0B
2025-12
Revenue YoY Growth
+6.7%
YoY Comparison
Gross Margin
29.5%
Latest Quarter
Free Cash Flow
$605000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CHDN Overvalued?
Because CHDN is profitable — trailing net income is positive with a trailing EPS of $0.047 (reflecting the most recent quarterly figure) and a trailing PE of 21.23x — the PE ratio is the appropriate primary valuation metric. The forward PE of 11.06x is dramatically lower than the trailing 21.23x, a gap that implies the market expects earnings to roughly double, consistent with analyst estimated EPS of $8.29 for the forward period versus the current depressed trailing figure. This wide trailing-to-forward spread suggests the market is pricing in a significant earnings recovery, likely driven by the Preakness IP acquisition, HRM expansion, and normalization of interest costs — but it also means the stock is priced for execution, and any disappointment would be punished severely given the already-weak price trend. On a price-to-sales basis, CHDN trades at 2.76x, and its EV/Sales of 3.49x and EV/EBITDA of 12.13x provide additional context for a capital-intensive, leveraged business. Peer comparison is challenging because the provided valuation data does not include explicit industry average multiples, but context can be drawn from the broader gaming sector: regional casino operators typically trade in the 8-12x EV/EBITDA range, and CHDN's 12.13x EV/EBITDA sits at the upper end of that band despite its recent underperformance, suggesting the market still ascribes a premium for the Derby brand and the Preakness acquisition. The PB ratio of 7.98x is elevated in absolute terms but is a function of the leveraged balance sheet rather than a pure growth premium, and the PEG ratio of -3.29 is not meaningful given the negative earnings growth trajectory implied by recent quarterly comparisons. Relative to its own history, CHDN's valuation has compressed dramatically: the historical PE ratio was 40.78x at Q4 2025, 44.99x at Q3 2025, and 34.41x at Q4 2024, versus the current 21.23x — so the stock is trading at roughly half its recent historical PE band. Similarly, the PS ratio has fallen from 12.20x at Q4 2025 and 15.81x at Q4 2024 to the current 2.76x, and the PB ratio has declined from 8.05x at Q4 2025 and 9.11x at Q4 2024 to 7.98x now. This compression reflects both the sharp price decline and the earnings recovery that has already begun to materialize, and it places the stock near the bottom of its multi-year valuation range — which could signal either a genuine value opportunity or a market that anticipates further fundamental deterioration. The forward PE of 11.06x versus a trailing PE of 21.23x is the single most important valuation signal: if the forward earnings estimate of $8.29 is achieved, the stock is remarkably cheap; if it is not, the current price may still be too high.
PE
21.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 5x~61x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are dominated by the company's extreme leverage: debt-to-equity of 5.15 and total debt-to-capitalization of 83.73% mean that interest expense of $75.6 million per quarter consumes the majority of operating income, leaving interest coverage at just 1.66x. The current ratio of 0.604 indicates current liabilities substantially exceed current assets, providing minimal liquidity cushion if operating cash flow deteriorates. Revenue concentration in the seasonal Kentucky Derby remains a structural vulnerability — Q2 2025 generated $934.4 million in revenue and $216.9 million in net income, while Q4 2025 produced only $665.9 million and $49.8 million, demonstrating extreme quarterly earnings volatility. The company's growth strategy depends on continued HRM expansion and the Preakness IP acquisition, both of which require capital expenditure that may further strain the balance sheet if free cash flow of $605 million TTM does not accelerate.
Market and competitive risks include valuation compression if the forward EPS estimate of $8.29 is not achieved, as the current forward PE of 11.06x already prices in a doubling of earnings from the trailing level. The stock's beta of 0.667 offers some downside protection relative to the broader market, but the 38.53 percentage point year-to-date underperformance versus SPY signals company-specific issues rather than macro-driven weakness. Regional casino operators typically trade at 8-12x EV/EBITDA, and CHDN's 12.13x multiple sits at the upper end of that band, leaving room for further de-rating if growth disappoints. The Preakness IP acquisition, while strategically sound, introduces integration risk and may not generate the stable revenue stream management anticipates if wagering trends continue to soften.
The worst-case scenario would involve a combination of continued revenue deceleration below 5%, failure to achieve the $8.29 forward EPS estimate, and a breach of the $79.40 52-week low triggering momentum-driven selling. In this scenario, the stock could retest its 52-week low of $79.40, representing a 3.1% decline from the current $81.91, but a more severe outcome could see the stock fall toward the $70-$75 range if the forward earnings estimate is cut by 15-20%. The maximum drawdown of -31.46% over the past year demonstrates the stock's capacity for significant declines, and the 30.8% gap between the current price and the 52-week high of $118.35 illustrates how far sentiment has deteriorated. From the current price, a realistic bear-case downside of 15-20% would put the stock in the $65-$70 range, implying a loss of $12-$17 per share.
FAQ
The most severe risk is financial: debt-to-equity of 5.15 and interest coverage of just 1.66x mean that any earnings decline could threaten the company's ability to service its debt, and the 0.604 current ratio provides minimal liquidity cushion. The second risk is earnings execution: Q4 2025 net income fell to $49.8 million from $71.7 million a year earlier despite revenue growth, and failure to achieve the $8.29 forward EPS estimate would make the current 11.06x forward PE look expensive. The third risk is competitive and market-related: regional casino operators typically trade at 8-12x EV/EBITDA, and CHDN's 12.13x multiple could compress further if gaming demand weakens or HRM expansion underperforms. The fourth risk is company-specific: the Preakness IP acquisition introduces integration risk and may not generate the stable revenue stream management anticipates, while the seasonal concentration in the Kentucky Derby creates extreme quarterly earnings volatility. Ranked by severity, the financial leverage risk is most critical, followed by earnings execution, competitive de-rating, and acquisition integration.
The 12-month forecast is distributed across three scenarios: a bull case with 25% probability targeting $130-$157 (average analyst target to high target), a base case with 50% probability targeting $100-$130 (analyst low target to average target), and a bear case with 25% probability targeting $70-$100 (below 52-week low to analyst low target). The base case is most likely, assuming revenue growth of 5-7% and forward EPS of $7.50-$8.00, slightly below the $8.29 consensus. The key assumption behind the base case is that the stock holds the $79.40 support level and gradually recovers as Preakness IP contributions materialize and HRM expansion continues. The bull case requires successful execution on the $8.29 EPS estimate and multiple expansion back toward historical levels, while the bear case assumes revenue growth decelerates below 4% and the forward EPS estimate is cut below $7.00. The wide target range reflects significant uncertainty about the earnings recovery trajectory.
CHDN appears undervalued relative to its own history but fairly valued relative to peers. The trailing PE of 21.23x is roughly half the historical range of 34-45x, and the PS ratio of 2.76x is down from 12.20x at Q4 2025, placing the stock near the bottom of its multi-year valuation range. However, the EV/EBITDA of 12.13x sits at the upper end of the 8-12x range typical for regional casino operators, suggesting the market still ascribes a premium for the Derby brand. The forward PE of 11.06x versus the trailing PE of 21.23x implies the market expects earnings to roughly double to $8.29, which is a high bar given the 6.68% revenue growth and 1.66x interest coverage. If the earnings recovery materializes, the stock is significantly undervalued; if it does not, the current price may still be too high. The market is pricing in a successful execution of the Preakness IP integration and HRM expansion, with little room for disappointment.
From a risk/reward perspective, CHDN offers 59.4% upside to the average analyst target of $130.58 against a downside risk of approximately 15-20% to the $65-$70 range if the forward EPS estimate is cut. The forward PE of 11.06x is compelling if the $8.29 consensus EPS is achieved, but the 1.66x interest coverage and 0.604 current ratio mean there is limited margin for error. The stock is best suited for patient value investors who can tolerate near-term volatility and have a 2-3 year horizon, as the Preakness IP acquisition and HRM expansion will take time to meaningfully contribute to earnings. For traders, the accelerating negative momentum and position just 2.1% above the 52-week low suggest waiting for a confirmed base before entering. A good entry point would be either a successful retest of the $79.40 support level or a breakout above the $90-$94 resistance zone on strong volume.
CHDN is better suited for long-term investment with a minimum holding period of 2-3 years, as the Preakness IP acquisition and HRM expansion will take time to meaningfully contribute to earnings and the deleveraging process is a multi-year endeavor. The beta of 0.667 indicates lower volatility than the broader market, which supports a longer holding period by reducing the risk of forced selling during market downturns. The dividend yield of just 0.38% with an 8.11% payout ratio means income generation is minimal, so the investment case rests entirely on capital appreciation from multiple expansion and earnings growth. Short-term trading is not recommended given the accelerating negative momentum, the stock's position just 2.1% above its 52-week low, and the lack of a confirmed technical base. Earnings visibility is low due to the seasonal Kentucky Derby concentration and the transformative Preakness acquisition, making it difficult to time short-term entries. A patient investor with a 2-3 year horizon could accumulate on weakness near the $79.40 support level, but should size positions conservatively given the 5.15 debt-to-equity ratio.